GnRH agonist

Goserelin updates

Answer

36 changes for Goserelin in the last 12 months. Latest: 2026-09-03.

DateTypeWhat changedSource
2026-09-03TrialNew trial registered: Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast CancerTrial register ClinicalTrials.gov
2026-09-02ResultsResults posted: Contributions to Hypertension With Androgen Deprivation TherapyTrial register ClinicalTrials.gov
2026-08-31ResultsResults posted: Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)Trial register ClinicalTrials.gov
2026-08-20TrialNew trial registered: QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant ChemotherapyTrial register ClinicalTrials.gov
2026-07-25TrialNew trial registered: Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate CancerTrial register ClinicalTrials.gov
2026-07-22TrialNew trial registered: ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV)Trial register ClinicalTrials.gov
2026-07-11TrialNew trial registered: Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast CancerTrial register ClinicalTrials.gov
2026-07-08ResultsResults posted: Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.Trial register ClinicalTrials.gov
2026-07-07TrialNew trial registered: Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.Trial register ClinicalTrials.gov
2026-07-02ResultsResults posted: Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients WiTrial register ClinicalTrials.gov
2026-05-27ResultsResults posted: Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed TumorsTrial register ClinicalTrials.gov
2026-05-14ResultsResults posted: A Study of Lerociclib in Participants With Advanced Breast CancerTrial register ClinicalTrials.gov
2026-05-14TrialNew trial registered: Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.Trial register ClinicalTrials.gov
2026-05-13TrialNew trial registered: BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed HypoTrial register ClinicalTrials.gov
2026-04-27TrialNew trial registered: Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic DiseTrial register ClinicalTrials.gov
2026-04-27TrialNew trial registered: Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using GoserelinTrial register ClinicalTrials.gov
2026-04-27TrialNew trial registered: Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell TransplantationTrial register ClinicalTrials.gov
2026-04-21TrialNew trial registered: A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate CancerTrial register ClinicalTrials.gov
2026-04-09ResultsResults posted: Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate CancerTrial register ClinicalTrials.gov
2026-03-25TrialNew trial registered: Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-RiTrial register ClinicalTrials.gov
2026-03-24LabelFDA label revised: ZOLADEX (NDA019726)Regulator FDA drug label register
2026-03-24LabelFDA label revised: ZOLADEX (NDA020578)Regulator FDA drug label register
2026-03-13TrialNew trial registered: Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate CanTrial register ClinicalTrials.gov
2026-03-12ResultsResults posted: Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer PatientsTrial register ClinicalTrials.gov
2026-03-10TrialNew trial registered: Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal HormonTrial register ClinicalTrials.gov
2026-02-25TrialNew trial registered: PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With UnfavorabTrial register ClinicalTrials.gov
2026-02-12TrialNew trial registered: A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have Trial register ClinicalTrials.gov
2026-01-29ResultsResults posted: Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandTrial register ClinicalTrials.gov
2026-01-28TrialNew trial registered: Radiotherapy After Prostatectomy for Node Positive Prostate CancerTrial register ClinicalTrials.gov
2025-12-28TrialNew trial registered: Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate CancerTrial register ClinicalTrials.gov
2025-12-28TrialNew trial registered: Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Trial register ClinicalTrials.gov
2025-12-18TrialNew trial registered: Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the TreatmenTrial register ClinicalTrials.gov
2025-12-17TrialNew trial registered: A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (Trial register ClinicalTrials.gov
2025-12-16TrialNew trial registered: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CanceTrial register ClinicalTrials.gov
2025-12-16TrialNew trial registered: Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)Trial register ClinicalTrials.gov
2025-11-16TrialNew trial registered: CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate CancerTrial register ClinicalTrials.gov
2025-09-18TrialNew trial registered: Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II StudyTrial register ClinicalTrials.gov
2025-09-05TrialNew trial registered: Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialTrial register ClinicalTrials.gov
2025-08-26TrialNew trial registered: Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPCTrial register ClinicalTrials.gov
2025-08-19TrialNew trial registered: Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseTrial register ClinicalTrials.gov
2025-08-10TrialNew trial registered: Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During ChemotherapyTrial register ClinicalTrials.gov
2025-08-01TrialNew trial registered: Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerTrial register ClinicalTrials.gov
2025-07-15TrialNew trial registered: A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male ParticipaTrial register ClinicalTrials.gov
2025-06-26ResultsResults posted: DeADT - Living Well With Prostate CancerTrial register ClinicalTrials.gov
2025-05-01TrialNew trial registered: Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine TherapyTrial register ClinicalTrials.gov
2025-04-16TrialNew trial registered: Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer PTrial register ClinicalTrials.gov
2025-04-03TrialNew trial registered: The COSMYC Trial (COmbined Suppression of MYC)Trial register ClinicalTrials.gov
2025-02-11ResultsResults posted: The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen DeprivationTrial register ClinicalTrials.gov
2025-01-19TrialNew trial registered: Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP PatientsTrial register ClinicalTrials.gov
2025-01-03TrialNew trial registered: Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPrTrial register ClinicalTrials.gov
2024-11-26ResultsResults posted: Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based CohortsTrial register ClinicalTrials.gov
2024-10-23TrialNew trial registered: Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-eTrial register ClinicalTrials.gov
2024-10-16ResultsResults posted: A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryTrial register ClinicalTrials.gov
2024-10-10TrialNew trial registered: Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast CancerTrial register ClinicalTrials.gov
2024-09-20ResultsResults posted: Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or PerimenopaTrial register ClinicalTrials.gov
2024-09-03TrialNew trial registered: Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)Trial register ClinicalTrials.gov
2024-08-28TrialNew trial registered: Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate CancerTrial register ClinicalTrials.gov
2024-07-31ResultsResults posted: A Study of PF-06873600 in People With CancerTrial register ClinicalTrials.gov
2024-07-26TrialNew trial registered: Effect of a GnRH Analog on Hepatic SteatosisTrial register ClinicalTrials.gov
2024-06-13TrialNew trial registered: Adaptions and Resiliency to Multi-Stressor OpeRationsTrial register ClinicalTrials.gov
2024-06-12TrialNew trial registered: Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast CancerTrial register ClinicalTrials.gov
2024-06-03TrialNew trial registered: Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast CancerTrial register ClinicalTrials.gov
2024-05-30TrialNew trial registered: Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate CancerTrial register ClinicalTrials.gov
2024-04-26TrialNew trial registered: To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate CancerTrial register ClinicalTrials.gov
2024-04-26TrialNew trial registered: Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)Trial register ClinicalTrials.gov
2024-04-23TrialNew trial registered: Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage RadiatTrial register ClinicalTrials.gov
2024-04-05ResultsResults posted: Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast CancerTrial register ClinicalTrials.gov
2024-04-04TrialNew trial registered: Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After SurgeryTrial register ClinicalTrials.gov
2024-03-27ResultsResults posted: Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+,Trial register ClinicalTrials.gov
2024-03-19ResultsResults posted: A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After RadTrial register ClinicalTrials.gov
2024-03-15ResultsResults posted: Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidTrial register ClinicalTrials.gov
2024-02-20ResultsResults posted: Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Trial register ClinicalTrials.gov
2024-02-19TrialNew trial registered: Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast CancerTrial register ClinicalTrials.gov
2024-01-25TrialNew trial registered: Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer PatientsTrial register ClinicalTrials.gov
2024-01-19TrialNew trial registered: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersTrial register ClinicalTrials.gov
2023-12-28TrialNew trial registered: First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HTrial register ClinicalTrials.gov
2023-12-20ResultsResults posted: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerTrial register ClinicalTrials.gov
2023-12-19TrialNew trial registered: DeADT - Living Well With Prostate CancerTrial register ClinicalTrials.gov
2023-12-11TrialNew trial registered: Intermittent Darolutamide Treatment in the Triple Therapy of mHSPCTrial register ClinicalTrials.gov
2023-11-24TrialNew trial registered: Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular TypingTrial register ClinicalTrials.gov
2023-09-21TrialNew trial registered: The Choice of Treatment Methods and Efficacy of LABCTrial register ClinicalTrials.gov
2023-09-17TrialNew trial registered: The Benefits of Continued Use of Ovarian Function Suppression After 5 YearsTrial register ClinicalTrials.gov
2023-09-15TrialNew trial registered: Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerTrial register ClinicalTrials.gov
2023-07-18TrialNew trial registered: Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer PatientsTrial register ClinicalTrials.gov
2023-07-18TrialNew trial registered: Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast CancerTrial register ClinicalTrials.gov
2023-07-09TrialNew trial registered: Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast CancerTrial register ClinicalTrials.gov
2023-07-06ResultsResults posted: Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerTrial register ClinicalTrials.gov
2023-06-12ResultsResults posted: Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-PositivTrial register ClinicalTrials.gov
2023-05-24TrialNew trial registered: Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)Trial register ClinicalTrials.gov
2023-05-23TrialNew trial registered: [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerTrial register ClinicalTrials.gov
2023-05-19TrialNew trial registered: Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-PosTrial register ClinicalTrials.gov
2023-05-12TrialNew trial registered: Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgTrial register ClinicalTrials.gov
2023-05-10ResultsResults posted: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate CancerTrial register ClinicalTrials.gov
2023-04-24TrialNew trial registered: Phase IIIb Study of Ribociclib + ET in Early Breast CancerTrial register ClinicalTrials.gov
2023-04-18ResultsResults posted: Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerTrial register ClinicalTrials.gov
2023-04-05TrialNew trial registered: Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in RussiaTrial register ClinicalTrials.gov
2023-03-26TrialNew trial registered: Fertility-sparing Therapy for Patients With Stage IA Endometrial CancerTrial register ClinicalTrials.gov
2023-03-26TrialNew trial registered: Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone ReceptoTrial register ClinicalTrials.gov
2023-03-23TrialNew trial registered: Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624Trial register ClinicalTrials.gov
2023-02-10TrialNew trial registered: To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or MifepristoneTrial register ClinicalTrials.gov

The 100 newest of 528 are listed.

From ClinicalTrials.gov, EU CTIS, FDA labels, recalls, shortages and warning letters, the Federal Register, and regulators' published actions. Not medical advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.